Sadar Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 8.00 M
as on 07-07-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 35.58%
(FY 2022)
- Profit 94.01%
(FY 2022)
- Ebitda 7.00%
(FY 2022)
- Net Worth 28.70%
(FY 2022)
- Total Assets 25.10%
(FY 2022)
About Sadar Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sayim Anwar, Arbab Uddin, and Shabab Uddin serve as directors at the Company.
- CIN/LLPIN
U24230HR1989PTC030531
- Company No.
030531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon Haryana, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sadar Laboratories Private Limited offer?
Sadar Laboratories Private Limited offers a wide range of products and services, including Popular Category, Mind Care, Stomach Care, Health Conditions, Mental Wellness, Women Care, Women Care Supplements, Sexual Wellness, Sexual Health Supplements, Liver Care.
Who are the key members and board of directors at Sadar Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shabab Uddin  | Managing Director | 04-Apr-1989 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sayim Anwar | Director | 09-Aug-2017 | Current |
| Arbab Uddin | Director | 04-Apr-1989 | Current |
Financial Performance of Sadar Laboratories.
Sadar Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.58% increase. The company also saw a substantial improvement in profitability, with a 94.01% increase in profit. The company's net worth Soared by an impressive increase of 28.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sadar Laboratories?
In 2022, Sadar Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Duke Rubber And Footcare Industries PvtltdActive 35 years 8 monthsSayim Anwar and Shabab Uddin are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sadar Laboratories?
Unlock and access historical data on people associated with Sadar Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sadar Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sadar Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
